STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Barclays Reports Zero Ownership in Verastem (VSTM) via Schedule 13G/A

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Verastem, Inc. received a Schedule 13G/A amendment from Barclays PLC reporting that Barclays holds 0.00 shares of Verastem common stock and asserts no voting or dispositive power. The filing classifies Barclays as a HC reporting person and states the holdings are in the ordinary course of business and not for the purpose of changing or influencing control.

The filing lists Barclays subsidiaries (Barclays Bank PLC, Barclays Capital Inc, Barclays Capital Securities Ltd) in connection with the parent holding company disclosure; overall the document indicates no material ownership position or control intent by Barclays in Verastem.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine disclosure; Barclays reports no beneficial ownership or voting power in VSTM.

The Schedule 13G/A shows 0.00 shares beneficially owned by Barclays PLC and zero sole or shared voting and dispositive power. This is a routine compliance filing confirming Barclays does not hold a reportable economic stake in Verastem and is not pursuing control. For investors, the filing does not change the ownership landscape or imply strategic moves by a major holder.

TL;DR: No governance impact; filing affirms ordinary-course holdings and no intent to influence control.

Barclays explicitly certifies the securities were acquired and are held in the ordinary course of business and not to influence control. The parent/ subsidiary disclosure names relevant Barclays entities but does not attach any material ownership. From a governance perspective, this filing provides transparency but signals no change in board or control dynamics at Verastem.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Barclays PLC
Signature:Ramya Rao
Name/Title:Director
Date:08/12/2025

FAQ

What does the Schedule 13G/A filed for VSTM disclose?

The filing states Barclays PLC beneficially owns 0.00 shares (0%) of Verastem common stock and reports no voting or dispositive power.

Does Barclays intend to influence control of Verastem (VSTM)?

No; the filing certifies the securities are held in the ordinary course of business and were not acquired to change or influence control.

Which Barclays entities are identified in the filing for VSTM?

The filing lists Barclays Bank PLC, Barclays Capital Inc, and Barclays Capital Securities Ltd in the parent/subsidiary disclosure.

How is Barclays classified in this Schedule 13G/A for VSTM?

Barclays PLC is classified as a reporting person type HC (parent holding company) in the filing.

Does the Schedule 13G/A indicate a material ownership stake in VSTM?

No; the filing states ownership of 0.00 shares, which represents 0% of the class and is below reportable thresholds.
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

801.40M
70.82M
0.82%
89.08%
25.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM